References
- AndréTBoniCMounedji-BoudiafLNavarroMTaberneroJHickishTTophamCZaninelliMClinganPBridgewaterJTabah-FischIde GramontAOxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. MOSAIC trialN Eng J Med2004350232343235110.1056/NEJMoa032709
- BeardSMHolmesMPriceCMajeedAWHepatic resection for colorectal liver metastases: A cost-effectiveness analysisAnn Surg2000232676377610.1097/00000658-200012000-00005
- BowlesCJALeicesterRRomayaCSwarbrickEWilliamsCBEpsteinOA prospective study of colonoscopy practice in the UK today: Are we adequately prepared for national colorectal cancer screening tomorrow?Gut20045327728310.1136/gut.2003.016436
- CeglowskiRChurilovLWasserthielJCombining data mining and discrete event simulation for a value-added view of a hospital emergency departmentJ Opns Res Soc20075824625410.1057/palgrave.jors.2602270
- Curtis L and Netten A (2005). Unit costs of health and social care. Personal social. Services Research Unit at the University of Kent.
- De ZwartIMGriffioenGShawMPCLamersCBHWde RoosABarium enema and endoscopy for the detection of colorectal neoplasia: Sensitivity, specificity, complications and its determinantsClin Radiol20015640140910.1053/crad.2000.0672
- Department of Health (2000). The NHS Cancer Plan: A plan for investment, a plan for reform. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4009609 (accessed 15 June 2006)
- Department of Health (2006a). Hospital episode statistics. http://www.dh.gov.uk/en/Publicationsandstatistics/Statistics/StatisticalWorkAreas/Statisticalworkareaneighbourhood/DH_4116710 (accessed 15 June 2006).
- Department of Health (2006b). NHS reference costs 2005. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4133221 (accessed 15 June 2006).
- Department of Health (2007). Cancer reform strategy. Guidance document for health and social care professionals.
- DinningJPHixsonLJClarkLCPrevalence of distal colonic neoplasia associated with proximal colon cancersArch Int Med199415485385610.1001/archinte.1994.00420080037004
- DunneJRGannonCJOsbornTMTaylorMDMaloneDLNapolitanoLMPreoperative anemia in colon cancer: Assessment of risk factorsAm Surgeon2002686582587
- FelliJCHazenGBA Bayesian approach to sensitivity analysisHealth Econ1999826326810.1002/(SICI)1099-1050(199905)8:3<263::AID-HEC426>3.0.CO;2-S
- FletcherAHalsallDHuxhamSWorthingtonDThe DH Accident and Emergency Department Model: A national generic model used locallyJ Opl Res Soc2007581554156210.1057/palgrave.jors.2602344
- GardenOJReesMPostonGJMirzaDSaundersMLedermannJPrimroseJNParksRWGuidelines for resection of colorectal cancer liver metastasesGut2006553iii1iii8
- GarthwaitePHChilcottJBJenkinsonDJTappendenPUse of expert knowledge in evaluating costs and benefits of alternative service provisions: A case studyInt J Technol Assess Health Care200824335035710.1017/S026646230808046X
- GattoNMFruchtHSundararajanVJacobsonJSGrannVRNeugutAIRisk of perforation after colonoscopy and sigmoidoscopy: A population-based studyJ Natl Cancer Inst200395323023610.1093/jnci/95.3.230
- Government Actuary's Department (2007). Interim life tables http://www.gad.gov.uk/Demography%20Data/Life%20Tables/Interim_life_tables.asp (accessed 15 June 2006).
- HealdRJChirMSmedhRKKaldASextonRMoranBJAbdominoperineal excision of the rectum—an endangered operationDis Colon Rectum199740774775110.1007/BF02055425
- Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A (2008). Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: Systematic review and economic evaluation (review of Guidance No. 33). Health Technol Assess 12(15).
- Lloyd-Jones M, Hummel S, Bansback N and Orr B (2001). A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. Health Technol Assess 5(25).
- KatsaliakiKBrailsfordSUsing simulation to improve the blood supply chainJ Opns Res Soc20065821922710.1057/palgrave.jors.2602195
- MawdsleySGlynne-JonesRGraingerJRichmanPMakrisAHarrisonMAshfordRHarrisonRAOsborneMLivingstoneJIMacDonaldPMitchellICMeyrick-ThomasJNorthoverJMWindsorANovellRWallaceMCan histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?Int J Radiat Oncol*Biol*Phys200563374575210.1016/j.ijrobp.2005.03.003
- Murray A, Lourenco T, de Verteuil R, Hernandez R, Fraser C, McKinley A, Krukowski Z, Vale L and Grant A (2006). Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: Systematic reviews and economic evaluation. Health Technol Assess 10(45).
- O'HaganABuckCDaneshkhahAEiserRGarthwaitePJenkinsonDOakleyJRakowTUncertain Judgements: Eliciting Experts' Probabilities2006
- Office for National Statistics (2007). Cancer registration statistics England 2005. http://www.statistics.gov.uk/ (accessed 15 December 2007).
- OsmanHSRashidNSathananthanNParkerMCThe cost effectiveness of self-expanding metal stents in the management of malignant left-sided large bowel obstructionColorectal Dis2000223323710.1046/j.1463-1318.2000.00140.x
- PandorAEggingtonSPaisleySTappendenPSutcliffePThe clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: Systematic review and economic evaluationHealth Technol Assess20061041118510.3310/hta10410
- PiddMComputer Simulation in Management Science2004
- PilgrimHChilcottJAssessment of a 7-day turn-around for the reporting of cervical smear results using discrete event simulationJ Opl Res Soc20085990291010.1057/palgrave.jors.2602431
- PinsonCWWrightJKChapmanWCGarrardCLBlairTKSawyersJLRepeat hepatic surgery for colorectal cancer metastasis to the liverAnn Surg1996223676577610.1097/00000658-199606000-00015
- RamseySDAndersenMREtzioniRMoinpourCPeacockSPotoskyAUrbanNQuality of life in survivors of colorectal carcinomaCancer20008861294130310.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.0.CO;2-M
- RenehanAGO'DwyerSTWhynesDKCost effectiveness analysis of intensive versus conventional follow-up after curative resection for colorectal cancerBr Med J20043287431818510.1136/bmj.328.7431.81
- RexDKRahmaniEYHasemanJHLemmelGTKasterSBuckleyJRelative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practiceGastroenterology1997112172310.1016/S0016-5085(97)70213-0
- RosenRSmithAHarrisonAFuture Trends and Challenges for Cancer Services in England: A Review of Literature and Policy2006
- Sebag-Montefiore D, Steele R, Quirke P, Grieve R, Khanna S, Monson J, Holliday A, Thompson L, Griffiths G and Stephens R (2006). Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. ASCO Annual Meeting.
- Seymour MT (2004). Optimizing the use and sequencing of fluorouracil, irinotecan and oxaliplatin in advanced colorectal cancer (ACRC): The UK MRC FOCUS. (CR08) Trial. Euro Soc Med Oncol, Conference Presentation.
- StevensonMBrazierJCalvertNLloyd-JonesMOakleyJKanisJDescription of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in womenJ Opl Res Soc20055621422110.1057/palgrave.jors.2601903
- TappendenPChilcottJEggingtonSPatnickJSakaiHKarnonJOption appraisal of population-based colorectal cancer screening programmes in EnglandGut20065667768410.1136/gut.2006.095109
- Tappenden, P, Chilcott, JB, Brennan A, Pilgrim H (2008). Modelling the bigger picture: Using service-level modelling to support consistent resource allocation decisions across whole disease areas. Health Technology Assessment International (HTAi) Fifth Annual Meeting, 8 July 2008; Montreal, Canada.
- Targownik LE, Spiegel BM, Sack J, Hines OJ, Dulai GS, Gralnek IM and Farrell JJ (2004) Colonic stent vs. emergency surgery for management of acute left-sided malignant colonic obstruction: A decision analysis. Gastrointest Endosc 60: 865–874.
- Tekkis PP, Smith JJ, Constantinides V, Thompson MR, Stamatakis JD (2005). Report of the National Bowel Cancer Audit Project ‘Knowing your results'.
- The Clinical Outcomes of Surgical Therapy Study Group (2006). A comparison of laparoscopically assisted and open colectomy for colon cancer: COST trial. N Eng J Med 350(20): 2050–2059.
- Trueman P, Chilcott J, Lowson K, Tappenden P, Bending M, Pilgrim H, Ganderton M, Chaplin S, Wright D, Shorthouse A, Duffy S, Tappenden J, Saxby R (2007a). Bowel cancer services: Costs and benefits. Summary report to the Department of Health.
- Trueman P, Lowson K, Bending M, Ganderton M, Saxby R, Lowson P, Whitehead S, Duffy S (2007b). Bowel cancer services: Costs and benefits. Lit Rev. Report to the Department of Health.
- TurnbullRBKyleKWatsonFRSprattJCancer of the colon: The influence of the no touch isolation technique on survival ratesAnn Surg1967166427
- TwelvesCWongANowackiMPAbtMBurrisHCarratoACassidyJCervantesAFagerbergJGeorgouliasVHusseiniFJodrellDKoralewskiPKröningHMarounJMarschnerNMcKendrickJPawlickiMRossoRSchüllerJSeitzJFStabucBTujakowskiJVan HazelGZaluskiJScheithauerWCapecitabine as adjuvant treatment for stage III colon cancer: X-ACT trialN Eng J Med2005352262696270410.1056/NEJMoa043116
- Ward S, Kaltenthaler E, Cowan J and Brewer N (2003). Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: Systematic review and economic evaluation. Health Technol Assess 7(32).
- WeinsteinMCStasonWBFoundations of cost-effectiveness analysis for health and medical practicesN Engl J Med197729671672110.1056/NEJM197703312961304
- WhynesDKCost-effectiveness of screening for colorectal cancer: Evidence from the Nottingham faecal occult blood trialJ Med Screen2004111111510.1258/096914104772950691